Latest News and Press Releases
Want to stay updated on the latest news?
-
BetaGlue Receives Belgium Ministry of Health Approval for YntraDose® Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
-
MHRA Approves BetaGlue Therapeutics’ Clinical Trial Application for YntraDose™ in unresectable Locally Advanced Pancreatic Cancer (uLPDAC)
-
BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer